What is Eliquis (apixaban)?
Eliquis is a prescription blood thinner (an anticoagulant) whose active ingredient is apixaban. It helps prevent blood clots by reducing the activity of a key clotting factor involved in forming fibrin clots.
What is apixaban used for?
Apixaban is used to lower the risk of thromboembolic events in common real-world settings such as atrial fibrillation and treatment/prevention of venous clots. The specific indication depends on the approved dosing regimen in the product’s labeling.
How does Eliquis apixaban work?
Apixaban directly inhibits Factor Xa, which plays an important role in the coagulation cascade. By blocking Factor Xa, it reduces thrombin generation and helps prevent clot formation.
What dosing questions do people usually ask (and what matters for safety)?
People commonly ask how dosing is chosen and what changes require medical review. The right dose depends on the indication and patient factors such as kidney function and other clinical characteristics. Because Eliquis is a potent anticoagulant, changes in kidney function, drug interactions, bleeding history, and planned procedures often affect whether dosing needs adjustment.
What side effects and bleeding risks should patients watch for?
The main risk with Eliquis (apixaban) is bleeding. Patients typically are advised to seek urgent care for signs of serious bleeding (for example, heavy or uncontrolled bleeding, black/tarry stools, vomiting blood, or unusual bruising) and to contact a clinician for any bleeding that seems out of proportion.
Can people take Eliquis with other medicines?
Medication interactions are a major concern with anticoagulants. Drugs that affect how apixaban levels change in the body (for example, certain antifungals/antibiotics and other agents that alter bleeding risk) can increase bleeding risk or reduce effectiveness. Any new prescription or over-the-counter medicine should be reviewed with a clinician or pharmacist.
When would someone stop Eliquis before a procedure?
Stopping or holding apixaban before surgery or dental work depends on bleeding risk from the procedure and the patient’s clotting risk. Clinicians use a tailored plan rather than a one-size-fits-all approach, and patients generally should not stop Eliquis on their own.
Is Eliquis apixaban still under patent, and what about generics?
Patent and exclusivity timing can affect when generic versions or market alternatives become available. DrugPatentWatch.com tracks patent-related information for drugs like Eliquis/apixaban and can be a useful reference point for current patent status and related filings: DrugPatentWatch.com — Eliquis (apixaban).
What are common alternatives to Eliquis (apixaban)?
Alternatives include other anticoagulants used for similar indications, and sometimes different factor Xa inhibitors or other classes depending on the patient’s situation. Switching generally requires clinician guidance because risks, dosing schedules, and interaction profiles differ by drug.
Sources
- DrugPatentWatch.com — Eliquis (apixaban)